TY - JOUR
T1 - A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa
AU - Grard, Gilda
AU - Fair, Joseph N.
AU - Lee, Deanna
AU - Slikas, Elizabeth
AU - Steffen, Imke
AU - Muyembe, Jean Jacques
AU - Sittler, Taylor
AU - Veeraraghavan, Narayanan
AU - Ruby, J. Graham
AU - Wang, Chunlin
AU - Makuwa, Maria
AU - Mulembakani, Prime
AU - Tesh, Robert B.
AU - Mazet, Jonna
AU - Rimoin, Anne W.
AU - Taylor, Travis
AU - Schneider, Bradley S.
AU - Simmons, Graham
AU - Delwart, Eric
AU - Wolfe, Nathan D.
AU - Chiu, Charles Y.
AU - Leroy, Eric M.
PY - 2012/9
Y1 - 2012/9
N2 - Deep sequencing was used to discover a novel rhabdovirus (Bas-Congo virus, or BASV) associated with a 2009 outbreak of 3 human cases of acute hemorrhagic fever in Mangala village, Democratic Republic of Congo (DRC), Africa. The cases, presenting over a 3-week period, were characterized by abrupt disease onset, high fever, mucosal hemorrhage, and, in two patients, death within 3 days. BASV was detected in an acute serum sample from the lone survivor at a concentration of 1.09×106 RNA copies/mL, and 98.2% of the genome was subsequently de novo assembled from ~140 million sequence reads. Phylogenetic analysis revealed that BASV is highly divergent and shares less than 34% amino acid identity with any other rhabdovirus. High convalescent neutralizing antibody titers of >1:1000 were detected in the survivor and an asymptomatic nurse directly caring for him, both of whom were health care workers, suggesting the potential for human-to-human transmission of BASV. The natural animal reservoir host or arthropod vector and precise mode of transmission for the virus remain unclear. BASV is an emerging human pathogen associated with acute hemorrhagic fever in Africa.
AB - Deep sequencing was used to discover a novel rhabdovirus (Bas-Congo virus, or BASV) associated with a 2009 outbreak of 3 human cases of acute hemorrhagic fever in Mangala village, Democratic Republic of Congo (DRC), Africa. The cases, presenting over a 3-week period, were characterized by abrupt disease onset, high fever, mucosal hemorrhage, and, in two patients, death within 3 days. BASV was detected in an acute serum sample from the lone survivor at a concentration of 1.09×106 RNA copies/mL, and 98.2% of the genome was subsequently de novo assembled from ~140 million sequence reads. Phylogenetic analysis revealed that BASV is highly divergent and shares less than 34% amino acid identity with any other rhabdovirus. High convalescent neutralizing antibody titers of >1:1000 were detected in the survivor and an asymptomatic nurse directly caring for him, both of whom were health care workers, suggesting the potential for human-to-human transmission of BASV. The natural animal reservoir host or arthropod vector and precise mode of transmission for the virus remain unclear. BASV is an emerging human pathogen associated with acute hemorrhagic fever in Africa.
UR - http://www.scopus.com/inward/record.url?scp=84866951390&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866951390&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.1002924
DO - 10.1371/journal.ppat.1002924
M3 - Article
C2 - 23028323
AN - SCOPUS:84866951390
SN - 1553-7366
VL - 8
JO - PLoS pathogens
JF - PLoS pathogens
IS - 9
M1 - e1002924
ER -